KLP Kapitalforvaltning AS Trims Holdings in Maximus, Inc. $MMS

KLP Kapitalforvaltning AS trimmed its stake in Maximus, Inc. (NYSE:MMS) by 17.2% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 21,200 shares of the health services provider’s stock after selling 4,400 shares during the period. KLP Kapitalforvaltning AS’s holdings in Maximus were worth $1,488,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Fuller & Thaler Asset Management Inc. raised its stake in shares of Maximus by 40.0% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider’s stock valued at $117,921,000 after acquiring an additional 494,372 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Maximus by 20.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider’s stock valued at $115,620,000 after acquiring an additional 288,990 shares during the period. Van Berkom & Associates Inc. raised its stake in shares of Maximus by 1.5% in the 1st quarter. Van Berkom & Associates Inc. now owns 1,275,394 shares of the health services provider’s stock valued at $86,969,000 after acquiring an additional 18,976 shares during the period. AQR Capital Management LLC raised its stake in shares of Maximus by 177.2% in the 1st quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider’s stock valued at $79,341,000 after acquiring an additional 750,031 shares during the period. Finally, Reinhart Partners LLC. raised its stake in shares of Maximus by 0.3% in the 2nd quarter. Reinhart Partners LLC. now owns 913,856 shares of the health services provider’s stock valued at $64,154,000 after acquiring an additional 2,345 shares during the period. 97.21% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider Michelle F. Link sold 1,610 shares of the company’s stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the transaction, the insider owned 13,508 shares in the company, valued at approximately $1,227,336.88. This represents a 10.65% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 1.60% of the company’s stock.

Maximus Trading Down 0.2%

Shares of NYSE:MMS opened at $85.31 on Tuesday. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.73. The company’s 50 day moving average is $86.92 and its two-hundred day moving average is $76.33. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. The company has a market cap of $4.81 billion, a PE ratio of 15.71 and a beta of 0.57.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same period in the prior year, the firm posted $1.74 EPS. The company’s quarterly revenue was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Equities analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be issued a $0.30 dividend. The ex-dividend date is Friday, November 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus’s dividend payout ratio is presently 22.10%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on MMS shares. Weiss Ratings raised shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, October 8th. Zacks Research raised shares of Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $90.00.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.